SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0000950123-22-010095
Filing Date
2022-10-07
Accepted
2022-10-07 16:41:30
Documents
11

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 4185015
2 filename2.htm EX-2 310604
3 GRAPHIC g2e1snf144qa000001.jpg GRAPHIC 104324
4 GRAPHIC g2e1snf144qa000002.jpg GRAPHIC 182001
5 GRAPHIC g2e1snf144qa000003.jpg GRAPHIC 182001
6 GRAPHIC g2e1snf144qa000004.jpg GRAPHIC 476312
7 GRAPHIC g2e1snf144qa000005.jpg GRAPHIC 272548
8 GRAPHIC g2e1snf144qa000006.jpg GRAPHIC 111187
9 GRAPHIC g2e1snf144qa000007.jpg GRAPHIC 121883
10 GRAPHIC g2e1snf144qa000008.jpg GRAPHIC 561471
11 GRAPHIC g2e1snf144qa000009.jpg GRAPHIC 44423
  Complete submission text file 0000950123-22-010095.txt   7329805
Mailing Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024
Business Address 12645 MEMORIAL DR., SUITE F1 #305 HOUSTON TX 77024 650.739.3939
Coya Therapeutics, Inc. (Filer) CIK: 0001835022 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-06324 | Film No.: 221301192
SIC: 2834 Pharmaceutical Preparations